Affiliation:
1. S.M. Kirov Military Medical Academy
Abstract
Type 2 diabetes mellitus (T2DM) is the cause of the development of diabetic nephropathy — a complication that determines the high degree of disability and mortality of such patients. Until recently, approaches to normalizing glucose levels did not have a significant possibility of influencing the outcome of kidney damage in diabetes. Type 2 sodium glucose cotransporter inhibitors (SGLT2) are a new class of glucose-lowering drugs that improve glycemic control due to an insulin-independent mechanism of action associated with increased urinary glucose excretion. The review provides an analysis of the results of studies on the assessment of nephroprotective actions — one of the pleiotropic actions of this drugs group. These materials show the properties of SGLT2 inhibitors to reduce the risk of developing and the progression of albuminuria, to save glomerular filtration rate, to reduce the frequency of end-stage renal disease and the need for renal replacement therapy in patients with T2DM. The article gives and analyzes the currently existing hypotheses of the mechanism of action of these glucose-lowering drugs. The risk of the most common renal complications with the use of SGLT2 inhibitors is considered. The practical aspects of the use of SGLT2 inhibitors in modern algorithms for the care of patients with T2DM are indicated, as well as the prospects for new randomized clinical trials.
Publisher
Endocrinology Research Centre
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference63 articles.
1. Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2017;12(12):2032-2045. https://doi.org/10.2215/CJN.11491116
2. Popov SI, Nagibovich OA, Kitsishin VP, Shustov SB. Non-invasive coronary blood flow estimation in type 2 diabetics with nephropathy. Vestnik Rossiiskoi voenno-meditsinskoi akademii. 2010; 4(32): 63-67. (in Russ.).
3. International Diabetes Federation. IDF Diabetes Atlas, 9th Edition [Internet], 2019. Available from http://diabetesatlas.org
4. Shamkhalova MS, Vikulova OK, Zheleznyakova AV, Isakov MA, Shestakova MV, Dedov II. Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013–2016). Diabetes mellitus. 2018;21(3):160-169. (in Russ.). https://doi.org/10.14341/DM9687
5. Shvetsov MYu, Bobkova IN, Kolina IB, Kamyshova ES. Khronicheskaya bolezn’ pochek i nefroprotektivnaya terapiya: metodicheskoe rukovodstvo dlya vrachei. M.: NONR, 2012. 83 s. (in Russ.).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献